Ligand validation:4CDC

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CDC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CDC_NAG_K_1369	45%	58%	0.17	0.902	0.51	1.07	-	1	0	0	100%	0.9333
4CDC_NAG_H_1369	38%	64%	0.169	0.87	0.53	0.84	-	1	0	0	100%	0.9333
4CDC_NAG_B_1369	36%	62%	0.154	0.848	0.54	0.89	-	-	1	0	100%	0.9333
4CDC_NAG_J_1120	36%	46%	0.189	0.884	0.43	1.64	-	2	0	0	100%	0.9333
4CDC_NAG_G_1120	36%	46%	0.185	0.878	0.61	1.47	-	4	0	0	100%	0.9333
4CDC_NAG_A_1120	28%	49%	0.214	0.867	0.66	1.3	-	3	0	0	100%	0.9333
4CDC_NAG_D_1119	28%	54%	0.179	0.829	0.51	1.26	-	2	0	0	100%	0.9333
6IC5_NAG_B_401	48%	41%	0.107	0.847	0.8	1.49	-	3	0	0	100%	0.9333
6IC7_NAG_B_401	39%	46%	0.116	0.821	0.76	1.3	-	1	0	0	100%	0.9333
4CDD_NAG_E_1368	36%	40%	0.216	0.911	0.52	1.78	-	4	0	0	100%	0.9333
4CDE_NAG_E_1368	28%	40%	0.234	0.888	0.54	1.77	-	4	0	0	100%	0.9333
6IC6_NAG_B_401	25%	23%	0.243	0.882	1.15	1.98	1	4	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.